跳至主要内容
临床试验/IRCT20091114002709N60
IRCT20091114002709N60招募中2 期

The effect of pomegranate peel supplementation on the serum levels of IL-6, IL-10, disease activity index and quality of life in patients with mild to moderate ulcerative colitis: a double-blind clinical trial.

Iran University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • 1. Patient consent to participate in the study
  • 2. Aged 18 years or older (age = 18 years)
  • 3. BMI above 18.5 and less than 30 kg/m2 (30 = BMI = 18.5)
  • 4. Diagnosis of ulcerative colitis by a specialist
  • 5. People with mild to moderate ulcerative colitis according to specialist diagnosis and the Partial Mayo scoring index
  • 6. Users of oral drugs of the 5-aminosalicylic acid group (pentasa, mesalazine or asacol, sulfasalazine) as well as immunomodulatory drugs (azathioprine, methotrexate, prograf, selpest or 6-mercaptopurine).

排除标准

  • 1. Changing the type and dosage of the drug used during the last month
  • 2. Pregnant or lactating women
  • 3. Suffering from other diseases, including digestive diseases, autoimmune diseases, cancer, inflammatory and infectious diseases
  • 4. Use of multivitamin-mineral, omega-3, polyphenolic, antioxidants, and herbal supplements during the past month (except for commonly prescribed supplements in ulcerative colitis)
  • 5. Use of corticosteroids, NSAIDs (profen, aspirin and diclofenac), and anti-TNF drugs (Cinnora or Adalimumab, Infliximab or Remicade)

研究者

相似试验

Investigating the effect of pomegranate peel... | 临床试验